Single-cell and spatial transcriptome profiling identifies the immunosuppressive spatial niche in KRAS -mutant colorectal cancer
Open Access
- 31 December 2025
- journal article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 13 (12) , e013763
Abstract
Background: KRAS is one of the most frequently mutated genes in colorectal cancer (CRC) and plays a crucial role in tumorigenesis, progression, immune evasion, and treatment resistance. The pronounced heterogeneity within KRAS -mutant CRC highlights the urgent need for more precise and personalized therapeutic approaches. Methods: To investigate this heterogeneity, we employed single-cell RNA sequencing and spatial transcriptomics to comprehensively characterize the tumor microenvironment of KRAS -mutant CRC. Data preprocessing and clustering were performed using Scanpy. Spatial cell-type deconvolution was conducted via Cell2location, whereas intercellular communication and spatial dependencies were analyzed using CellChat, MISTy, and stLearn. Results: Our analyses revealed that KRAS -mutant tumor epithelial cells recruit Mono_ S100A8 monocytes via the MDK_SDC4 signaling axis. Concurrently, surrounding Fib_ CTHRC1 fibroblasts secrete collagen, which interacts with integrin receptors on KRAS -mutant epithelial cells and contributes to the exclusion of lymphocyte infiltration. Conclusion: These cellular components collaboratively established an immunosuppressive spatial niche. These findings offer novel theoretical insights and potential targets for the development of immunoregulatory strategies tailored to KRAS -mutant CRC.Keywords
Funding Information
- The Gusu Health Talent Programme Research Project (GSWS2023058)
- National Natural Science Foundation of China (82273406)
- National Natural Science Foundation of China (82303086)
- Suzhou Applied Basic Research (Medical and Health) Technology Innovation Project (SYW2024112)
This publication has 69 references indexed in Scilit:
- Hepatic stellate cells promote hepatocellular carcinoma development by regulating histone lactylation: Novel insights from single-cell RNA sequencing and spatial transcriptomics analysesCancer Letters, 2024
- Triple combination therapy comprising osimertinib, an AXL inhibitor, and an FGFR inhibitor improves the efficacy of EGFR-mutated non-small cell lung cancerCancer Letters, 2024
- PDP1 promotes KRAS mutant colorectal cancer progression by serving as a scaffold for BRAF and MEK1Cancer Letters, 2024
- scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20+ B cellsCancer Letters, 2024
- CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15Journal of Molecular Medicine, 2023
- S100A8 and S100A9 in CancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023
- Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T‐Cells to Activation‐Induced Cell Death in Colorectal CancerAdvanced Science, 2023
- The Illumina Sequencing Protocol and the NovaSeq 6000 System2021
- S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancerCancer Communications, 2021
- Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapyCancer Communications, 2020